It was concluded that Annexin A1 is a pivotal regulator of RhoA activity, restoring IRS-1 signaling, and that hrANXA1 may offer therapeutic benefit for complications of type 2 diabetes mellitus. The gene discussed is ANXA1; the disease is type 2 diabetes mellitus.